1. 18TiPDESIGN OF A PHASE 2 STUDY OF BRENTUXIMAB VEDOTIN (SGN-35) AS SALVAGE THERAPY FOR MALES WITH CHEMORESISTANT GERM-CELL TUMORS (GCT). (November 2014) Authors: Giannatempo, P.; Anichini, A.; Raggi, D.; Cordareschi, E.; Nicolai, N.; Colecchia, M.; Salvioni, R.; Valagussa, P.; Gianni, A.; Necchi, A. Journal: Annals of oncology Issue: Volume 25(2014)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗